The Future of Clinical Trial Data in Decentralisation Models
The landscape of clinical research is undergoing a seismic shift, powered by technological advancement, shifting patient expectations, and a worldwide drive for more effective...
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
GSK plc announced it has entered into agreements with Hengrui Pharma to develop up to 12 innovative medicines, adding significant new growth opportunities to...
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
Aptar Pharma, a global leader in drug delivery and active material science solutions and services, announced its acquisition of the clinical trial materials manufacturing...
FDA Accepts BLA for Recommended Biosimilar to Simponi
Bio-Thera Solutions announced that the FDA has accepted its Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi® (golimumab). The FDA goal...
Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug
Merck to acquire Verona Pharma, a UK-based pharmaceutical company in a $10 billion acquisition, adding the promising respiratory drug Ohtuvayre into its pipeline as...
Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases
The landscape of medicine is ever-changing, and progress is obvious in developing treatments for ultra-rare disorders. Ultra-rare disorders are characterised as infrequently recognised conditions...
FDA Approves Oral Therapy for Treating Hereditary Angioedema
The US Food and Drug Administration (FDA) has approved the first on-demand oral therapy for the treatment of acute attacks of hereditary angioedema (HAE)...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...